Quanterix Awarded Grant From GE Corporation And The NFL’s Head Health Challenge

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that they have been selected as a winner of the GE and NFL Head Health Challenge from more than 400 entries across 27 countries by a panel of leading healthcare experts in brain research, imaging technologies and advocates for the advancement of brain research. This grant provides funding to help further advance development of tests to quickly diagnose traumatic brain injuries through their ultra sensitive Simoa™ technology that measures molecular signatures (biomarkers) of brain injury in blood.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC